Although the primary impact of Semaglutide is on glucose metabolism and appetite regulation through GLP-1 receptor pathways, there exists an indirect possibility for these mechanisms to affect blood flow

Contact your healthcare provider before combining medications if you: Have pre-existing liver or kidney disease, as these conditions may affect how both medications are processed by your body Are taking multiple medications regularly, particularly those metabolised by the liver Have a history of alcohol dependency or regularly consume more than 14 units of alcohol per week Are pregnant, planning pregnancy, or breastfeeding (remember: Wegovy must be stopped at least 2 months before planned conception) Have experienced previous adverse reactions to either paracetamol or GLP-1 receptor agonists Seek urgent medical attention if you experience: Signs of paracetamol overdose : If you suspect you've taken too much paracetamol, seek immediate same-day medical help (NHS 111, urgent care centre or A&E) even if you have no symptoms
Headaches: Some patients may experience headaches, which can often be managed with over-the-counter pain relievers
95% CI: 3.44 to 1.68) did not lead to statistically significant changes
OTC Option: Start a 14-day cycle of Omeprazole (Prilosec) to shut down the stomach's proton pumps completely
This June, 2023, NEJM article, TripleHormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial, reviews its triple mechanism of action